Table 1

Patient characteristics (FAS; n=200)

N (%) or mean±SD
Age (years)62.2±10.5
Female gender68 (34.0)
Weight (kg)84.9±15.1
BMI (kg/m2) (n=198)28.5±4.5
 <18.5 kg/m²0 (0)
 18.5 to <25 kg/m²45 (22.7)
 25 to <30 kg/m²90 (45.5)
 ≥30 kg/m²63 (31.8)
Systolic BP (mm Hg)131.5±14.9
Diastolic BP (mm Hg)78.2±8.9
Dyslipidaemia
 FH95 (47.7; 95% CI 40.6 to 54.9)
 Non-familial hypercholesterolaemia93 (48.9; 95% CI 41.6 to 56.3)
 Mixed dyslipidaemia84 (43.8; 95% CI 36.6 to 51.1)
 None of the above or missing information9 (4.5; 95% CI 2.1 to 8.4)
 Statin contraindication (n=195)90 (46.2)
 Statin intolerance (n=199)127 (63.8)
Cardiovascular disease
 Any cardiovascular disease200 (100)
 CHD197 (98.5)
 Status post ACS169 (84.5)
 Hypertension147 (74.6)
 Heart failure29 (15.5)
 PAD26 (13.7)
 Stroke17 (8.9)
 Transient ischaemic attack7 (3.7)
Diabetes mellitus (n=195)
 Type 16 (3.1)
 Type 251 (26.2)
Disease management programme (n=197)45 (22.8)
  • ACS, acute coronary syndrome; BMI, body mass index; BP, blood pressure; CHD, coronary heart disease; FAS, full analysis set; FH, familial hypercholesterolaemia; PAD, peripheral artery disease.